Ridgeback Biotherapeutics

filter Active Ingredients

All (1)

01 ANSUVIMAB-ZYKL (1)

filter Applicant

All (1)

01 RIDGEBACK BIOTHERAPEUTICS (1)

filter Dosage Form

All (1)

01 POWDER;IV (INFUSION) (1)

filter Dosage

All (1)

01 400MG/VIAL (1)

filter Country

All (1)

01 USA (1)

Ridgeback Biotherapeutics's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass